As of Oct 2, 2026 close
- Market cap
- $45.45M
- P/E (TTM)
- 57.61
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $0.37$8.08
- Volume (live)
- —
- Avg. volume (3M)
- 20.46K
Impact BioMedical (IBO) Stock Price & Financial Analysis
Impact BioMedical Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $5.27 - $5.54 |
|---|---|
| 52-Week High | $8.08 |
| 52-Week Low | $0.37 |
| Open | $5.54 |
| Volume (last close) | 10.83K |
| Average Volume (3M) | 20.46K |
| Market Cap | 45.45M |
|---|---|
| Shares Outstanding | 8.54M |
| P/E Ratio (TTM) | 57.61 |
| Price to Sales (P/S) | 1298.64 |
| Price to Book (P/B) | 4.22 |
| EV/EBITDA | -113.32 |
| Revenue (TTM) | 35.00K |
|---|---|
| Net Income (TTM) | 789.00K |
| Free Cash Flow (TTM) | -508.00K |
| EPS (TTM) | $0.03 |
| Profit Margin | 2254.29% |
| Operating Margin | -14562.86% |
| Return on Equity (ROE) | 7.33% |
| Debt to Equity | 0.00 |
| 50-Day MA | $5.86 |
|---|---|
| 200-Day MA | $2.46 |
| 52-Week Change | +725.32% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Last Dividend Ex-Date | May 14, 2020 |
Impact BioMedical at a Glance
Impact BioMedical (IBO) has a market capitalization of $45.45M. The stock trades at 57.6× trailing earnings and 1298.6× sales. Over the trailing twelve months it earned $789.00K on revenue of $35.00K (a 2254.3% profit margin) and burned $508.00K of free cash flow. Revenue grew 400.0% year over year.
It holds $10.00K in cash and securities against $0.00 of debt, a net cash position of $10.00K.
Impact BioMedical does not currently pay a dividend.
The share price is up 736.5% over the past year. At $5.32 it sits within its 52-week range of $0.37 to $8.08, above its 200-day moving average of $2.46.
Frequently Asked Questions About Impact BioMedical
What is the current stock price for IBO?
As of the Oct 2, 2026 close, IBO stock trades at $5.32. The 52-week range is $0.37–$8.08, with a day range of $5.26–$5.54.
What is the P/E ratio for IBO?
Impact BioMedical's trailing P/E ratio is 57.6, meaning investors pay $57.6 for every $1 of annual earnings. Impact BioMedical operates in the Healthcare sector.
Does IBO pay dividends?
Impact BioMedical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IBO?
Analyst ratings and recommendations for IBO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IBO?
Impact BioMedical's market capitalization is $45.5M, classifying it as a micro-cap company. Impact BioMedical operates in the Healthcare sector within the Biotechnology industry.